Respiratory Medication Articles & Analysis
8 news found
” In the abstract, Anticipating acute deterioration in respiratory disease using remote monitoring of respiratory force, researchers retrospectively analyzed the chart data of 164 pulmonary patients enrolled on Spire RPM who were escalated to their provider at the Pulmonary Associates of Richmond (Richmond, VA). The 68.6% of the escalations that were found ...
Their team’s clinical, fundraising and business development experience will help Stemedica advance our best-in-class stem cell technology to treat those with medical conditions resulting from COVID-19 or other pulmonary indications targeted by Pulthera.” Pulthera, a Delaware Incorporated Limited Liability Corporation, was formed for the express purpose of advancing ...
Using the MediPines AGM100®, a respiratory medical device,researchers were able to demonstrate that the new breath-based measurement of gas exchange efficiency has very low variability and is highly correlated with established blood-sampling methods. ...
To meet this growing challenge in the face of rising pandemic, MediPines, a respiratory medical device company, has released a scientific paper on respiratory monitoring in long-term care facilities. ...
Launched in July of 2020, this challenge aims to foster collaboration between medical and technology providers to improve the delivery of healthcare in Georgia. ...
MediPines, a respiratory medical device company, was selected a winner in the special COVID-19 edition of the “Make Your Medical Device Pitch for ...
On March 7th, YAGUO sent to Hubei a new set of respiratory devices, the number goes up to 100 devices worth around 2.2 million RMB, including bionic cough simulator (sputum removal system), respiratory dynamics (respiratory neuromuscular stimulator), and cuff pressure gauge (balloon manometers). All these innovating devices will be donated to ...
Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use in metered-dose inhalers (MDIs) for treatment of respiratory disorders such as asthma and chronic ...
ByKoura